# The SPOT-HPV Study

> **NCT05524025** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 360 (actual)

## Conditions studied

- HPV Infection
- HPV Positive Oropharyngeal Squamous Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Salivary TTMV-HPV DNA Test
- **DIAGNOSTIC_TEST:** Blood TTMV-HPV DNA Test

## Key facts

- **NCT ID:** NCT05524025
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-30
- **Primary completion:** 2024-09-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05524025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05524025, "The SPOT-HPV Study". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05524025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*